Expert second opinions for septal myectomy. Dual-physician Heart Team review with triple risk scoring. Results in 24 hours.
Septal Myectomy (Morrow procedure) is the surgical treatment for hypertrophic cardiomyopathy (HCM) with left ventricular outflow tract (LVOT) obstruction. If you are facing a decision about septal myectomy, an independent Heart Team second opinion can confirm whether surgery is the right choice and identify alternatives. WhiteGloveMD delivers dual-physician review with STS, EuroSCORE II, and AATS risk scoring in 24 hours. Get an independent second opinion →
Septal myectomy (Morrow procedure) is the surgical treatment for hypertrophic cardiomyopathy (HCM) with left ventricular outflow tract (LVOT) obstruction. The operation removes a portion of the thickened interventricular septum, relieving the obstruction. At experienced centers, the procedure has mortality under 1% with >90% success in gradient reduction.
Septal myectomy outcomes are extraordinarily surgeon- and center-dependent. Guidelines recommend the procedure be performed at centers with >50 myectomies per year, yet most are performed at low-volume centers with significantly worse outcomes. A second opinion from an HCM center of excellence can be the difference between an excellent result and a complication.
Surgery for septal myectomy depends on symptom severity, imaging findings, and risk profile. Guidelines from the AHA/ACC define specific thresholds, but many patients fall into gray zones where a second opinion meaningfully changes the recommendation. Septal myectomy outcomes are extraordinarily surgeon- and center-dependent. Guidelines recommend the procedure be performed at centers with >50 myectomies per year, yet most are performed at low-volume centers with significantly worse outcomes. A second opinion from an HCM center of excellence can be the difference between an excellent result and a complication.
Operative mortality for septal myectomy-related cardiac surgery is calculated using validated models including STS PROM, EuroSCORE II, and AATS. Individual risk depends on age, comorbidities, frailty, ejection fraction, and surgeon/center volume. Our free calculator at whiteglovemd.com/tools/risk-calculator estimates your specific risk across all three models in real time.
Yes. Studies show that 30-40% of expert cardiac surgery second opinions change the original treatment plan — sometimes by recommending less-invasive alternatives, sometimes by clarifying that watchful waiting is safer. WhiteGloveMD pairs a cardiac surgeon and cardiologist with our Clintelligence multi-agent AI pipeline to deliver an independent review in 24 hours, starting at $500.
The optimal treatment for septal myectomy depends on anatomy, comorbidities, age, and personal goals. Myectomy vs alcohol septal ablation. A Heart Team review evaluates every viable option — including transcatheter approaches, repair vs replacement, and surgeon/center matching — rather than defaulting to a single recommendation.
WhiteGloveMD delivers a dual-physician, AI-augmented second opinion in 24 hours. Starting at $500.